News
NVS
97.11
+0.35%
0.34
Weekly Report: what happened at NVS last week (1216-1220)?
Weekly Report · 5h ago
Hunterbrook Capital long Bioage Labs, Hunterbrook Media reports
TipRanks · 2d ago
European stocks that trade cheaper than U.S. peers
Seeking Alpha · 3d ago
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Benzinga · 3d ago
MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease
NASDAQ · 3d ago
Novartis to close MorphoSys sites in Boston, Munich: report
Seeking Alpha · 3d ago
Novartis AG (NOVN) Gets a Sell from Barclays
TipRanks · 4d ago
CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts
Benzinga · 4d ago
BioAge, Novartis team up to discover age-related disease targets
Seeking Alpha · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-BioAge Labs, Expedia, Citizens Financial Group
Reuters · 4d ago
CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana
Benzinga · 4d ago
BioAge Stock Advances 14% On Novartis Research Collaboration
Dow Jones · 4d ago
BUZZ-BioAge Labs rises on Novartis collaboration for age-related disease drugs
Reuters · 4d ago
BioAge Labs announces multi-year collaboration with Novartis
TipRanks · 5d ago
BioAge Labs Announces Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions; Novartis To Pay Up To $20M Comprising Upfront Payments And Research Funding; BioAge May Receive Up To $530M In Future Long-Term Research, Development, And Commercial Milestones
Benzinga · 5d ago
Alcon a top pick for 2025 at Needham on upcoming product launches
Seeking Alpha · 5d ago
SCHY Vs. IGRO: Comparing Two Top Low P/E International Dividend Growth ETFs
Seeking Alpha · 5d ago
NVS vs. LLY: Which Stock Should Value Investors Buy Now?
NASDAQ · 5d ago
Deutsche Bank Remains a Hold on Novartis AG (NOVN)
TipRanks · 6d ago
Weekly Report: what happened at NVS last week (1209-1213)?
Weekly Report · 12/16 09:27
More
Webull provides a variety of real-time NVS stock news. You can receive the latest news about Novartis through multiple platforms. This information may help you make smarter investment decisions.
About NVS
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.